Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heard

Showing results (71-80 of 299) with videos related to

Pageof 30
Sort By:
Methods in Enzymology|January 1, 1995
Replication-competent and -defective retrovirus vectors for oncogenic studiesJ Samarut, F Flamant, J M Heard
La Revue Du Praticien|January 15, 1997
[Principles and stakes of gene therapy]P Moullier, N Ferry, J M Heard
International Journal of Pharmaceutics|October 7, 2008
Permeation of quinine across sublingual mucosa, in vitroCharlene M Y Ong, Charles M Heard
Journal of Virology|May 18, 2001
Transmembrane topology of PiT-2, a phosphate transporter-retrovirus receptorC Salaün, P Rodrigues, J M Heard
La Revue Du Praticien|November 15, 1993
[The liver and gene therapy. Experimental or revolutionary procedure?]D Houssin, O Danos, J M Heard
Nanotoxicology|December 1, 2012
The effects of topically applied polyNIPAM-based nanogels and their monomers on skin cyclooxygenase expression, ex vivoNor H Abu Samah, Charles M Heard
Journal of Applied Microbiology|March 24, 2006
Lactic acid bacteria associated with wine grapes from several Australian vineyardsS Bae, G H Fleet, G M Heard
Journal of Cellular Physiology|September 1, 1985
The in vitro autocrine secretion of CSFs alone does not account for the longterm growth of murine myeloid leukemic cells in suspension culturesS Fichelson, J M Heard, J P Levy
Lancet (London, England)|July 19, 2001
Neonatal group B streptococcal infectionE Halliday, K Foote, M Dryden, et al.
Pharmaceutical Research|June 24, 2004
In vitro delivery of novel, highly potent anti-varicella zoster virus nucleoside analogues to their target site in the skinChris A Jarvis, Chris McGuigan, Charles M Heard
Pageof 30

Showing results (71-80 of 299) with videos related to

Sort By:
Pageof 30
Methods in Enzymology|January 1, 1995
Replication-competent and -defective retrovirus vectors for oncogenic studiesJ Samarut, F Flamant, J M Heard
La Revue Du Praticien|January 15, 1997
[Principles and stakes of gene therapy]P Moullier, N Ferry, J M Heard
International Journal of Pharmaceutics|October 7, 2008
Permeation of quinine across sublingual mucosa, in vitroCharlene M Y Ong, Charles M Heard
Journal of Virology|May 18, 2001
Transmembrane topology of PiT-2, a phosphate transporter-retrovirus receptorC Salaün, P Rodrigues, J M Heard
La Revue Du Praticien|November 15, 1993
[The liver and gene therapy. Experimental or revolutionary procedure?]D Houssin, O Danos, J M Heard
Nanotoxicology|December 1, 2012
The effects of topically applied polyNIPAM-based nanogels and their monomers on skin cyclooxygenase expression, ex vivoNor H Abu Samah, Charles M Heard
Journal of Applied Microbiology|March 24, 2006
Lactic acid bacteria associated with wine grapes from several Australian vineyardsS Bae, G H Fleet, G M Heard
Journal of Cellular Physiology|September 1, 1985
The in vitro autocrine secretion of CSFs alone does not account for the longterm growth of murine myeloid leukemic cells in suspension culturesS Fichelson, J M Heard, J P Levy
Lancet (London, England)|July 19, 2001
Neonatal group B streptococcal infectionE Halliday, K Foote, M Dryden, et al.
Pharmaceutical Research|June 24, 2004
In vitro delivery of novel, highly potent anti-varicella zoster virus nucleoside analogues to their target site in the skinChris A Jarvis, Chris McGuigan, Charles M Heard
Pageof 30